Evidence map›Paper›PMID 29176913›Full record

ArticleJournal of drug issues2017

Addiction Treatment Clients' Reactions to Graphic Warning Labels on Cigarette Packs.

Anna Pagano, Noah Gubner, Barbara Tajima, Deborah Yip, Catherine Henderson, Joseph Guydish

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of drug issues, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anna PaganoPrevention Research Center, Pacific Institute for Research and Evaluation, Oakland, CA, USA.
Noah GubnerPhilip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, USA.
Barbara TajimaPhilip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, USA.
Deborah YipPhilip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, USA.
Catherine HendersonPhilip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, USA.
Joseph GuydishPhilip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, USA.
University of California, San Francisco · USPacific Institute For Research and Evaluation · US

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Kate Taylor Shumate · 1999 to 2026
$209.7M
Substance Use Disorders Treatment/Services Research Training ProgramT32DA007250 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Derek D Satre, Janice Y Tsoh · 1991 to 2026
$7.4M
Marketing, FDA communication, tobacco perceptions and use in addiction treatmentR01DA036066 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GUYDISH, JOSEPH R · 2013 to 2016
$3.0M
NCI NIH HHS P30 CA082103NIDA NIH HHS R01 DA036066NIDA NIH HHS T32 DA007250
6 · The paper itself

Abstract

Graphic warning labels (GWLs) on cigarette packs have been tested among diverse groups at high risk for tobacco use. However, little is known about the effectiveness of GWL interventions for persons with substance use disorders, whose smoking prevalence is 3 to 4 times that of the general population. After an experimental study which exposed clients in residential addiction treatment to GWLs for 30 days, we conducted five focus groups with trial participants (

Indexed as

addiction treatmentgraphic warning labelssmoking cessationsubstance abuse

Identifiers

PMID29176913
PMCPMC5699470
OpenAlexW2598541339

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.